

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.64397729 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.64397729 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.30254747 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.30254747 |
| 5 | exogenous drug catabolic process (GO:0042738) | 6.96761897 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.87428538 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.18755826 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.18755826 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.18755826 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.08204030 |
| 11 | bile acid biosynthetic process (GO:0006699) | 6.01452441 |
| 12 | * triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.00765257 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.85677778 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.82908644 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.76519499 |
| 16 | urea metabolic process (GO:0019627) | 5.70756340 |
| 17 | urea cycle (GO:0000050) | 5.70756340 |
| 18 | epoxygenase P450 pathway (GO:0019373) | 5.69277823 |
| 19 | omega-hydroxylase P450 pathway (GO:0097267) | 5.68286115 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.63021150 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.55123644 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45390418 |
| 23 | protein carboxylation (GO:0018214) | 5.45390418 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.44455832 |
| 25 | cysteine metabolic process (GO:0006534) | 5.42661798 |
| 26 | * high-density lipoprotein particle remodeling (GO:0034375) | 5.37789741 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.34891010 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.34521257 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.24459875 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.18465532 |
| 31 | bile acid metabolic process (GO:0008206) | 5.15353025 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 5.00862903 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.99232917 |
| 34 | regulation of complement activation (GO:0030449) | 4.97521801 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91110961 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.90089007 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.85649244 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.76878829 |
| 39 | phospholipid efflux (GO:0033700) | 4.69518446 |
| 40 | negative regulation of cholesterol transport (GO:0032375) | 4.69160726 |
| 41 | negative regulation of sterol transport (GO:0032372) | 4.69160726 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.68348984 |
| 43 | * reverse cholesterol transport (GO:0043691) | 4.64453292 |
| 44 | * protein-lipid complex remodeling (GO:0034368) | 4.64316413 |
| 45 | * macromolecular complex remodeling (GO:0034367) | 4.64316413 |
| 46 | * plasma lipoprotein particle remodeling (GO:0034369) | 4.64316413 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.62317961 |
| 48 | lysine catabolic process (GO:0006554) | 4.60062766 |
| 49 | lysine metabolic process (GO:0006553) | 4.60062766 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.56660226 |
| 51 | glycine metabolic process (GO:0006544) | 4.52236386 |
| 52 | * acylglycerol homeostasis (GO:0055090) | 4.46951291 |
| 53 | * triglyceride homeostasis (GO:0070328) | 4.46951291 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.45637258 |
| 55 | * low-density lipoprotein particle remodeling (GO:0034374) | 4.44335943 |
| 56 | imidazole-containing compound metabolic process (GO:0052803) | 4.41020781 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 4.38572609 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.36064764 |
| 59 | cholesterol efflux (GO:0033344) | 4.32793274 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.31081226 |
| 61 | intestinal cholesterol absorption (GO:0030299) | 4.30202937 |
| 62 | cellular glucuronidation (GO:0052695) | 4.29796954 |
| 63 | amine catabolic process (GO:0009310) | 4.29227362 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.29227362 |
| 65 | glutamate metabolic process (GO:0006536) | 4.26721014 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.23718783 |
| 67 | drug metabolic process (GO:0017144) | 4.23571230 |
| 68 | * plasma lipoprotein particle clearance (GO:0034381) | 4.20476625 |
| 69 | negative regulation of blood coagulation (GO:0030195) | 4.19620543 |
| 70 | negative regulation of hemostasis (GO:1900047) | 4.19620543 |
| 71 | positive regulation of hemostasis (GO:1900048) | 4.19121726 |
| 72 | positive regulation of blood coagulation (GO:0030194) | 4.19121726 |
| 73 | ethanol oxidation (GO:0006069) | 4.15265942 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 4.15081548 |
| 75 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.11281408 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 4.11124372 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 4.10927789 |
| 78 | aldehyde catabolic process (GO:0046185) | 4.10912913 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08553410 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 4.08124802 |
| 81 | fibrinolysis (GO:0042730) | 4.07498292 |
| 82 | arginine metabolic process (GO:0006525) | 4.06705497 |
| 83 | oxidative demethylation (GO:0070989) | 4.06155963 |
| 84 | negative regulation of protein activation cascade (GO:2000258) | 3.96281385 |
| 85 | ketone body metabolic process (GO:1902224) | 3.95348233 |
| 86 | blood coagulation, intrinsic pathway (GO:0007597) | 3.94284802 |
| 87 | drug catabolic process (GO:0042737) | 3.93174137 |
| 88 | complement activation, classical pathway (GO:0006958) | 3.89554654 |
| 89 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86248514 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86248514 |
| 91 | negative regulation of coagulation (GO:0050819) | 3.86094095 |
| 92 | complement activation (GO:0006956) | 3.84061920 |
| 93 | cofactor catabolic process (GO:0051187) | 3.82308058 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81634459 |
| 95 | protein activation cascade (GO:0072376) | 3.81576930 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.81008697 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.81008697 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 3.80759195 |
| 99 | regulation of plasminogen activation (GO:0010755) | 3.80073023 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.79304429 |
| 101 | positive regulation of coagulation (GO:0050820) | 3.78792349 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.77574485 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.77262898 |
| 104 | organic acid catabolic process (GO:0016054) | 3.77262898 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.71179335 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71095453 |
| 107 | protein-lipid complex assembly (GO:0065005) | 3.69257641 |
| 108 | S-adenosylmethionine metabolic process (GO:0046500) | 3.68365696 |
| 109 | * cholesterol homeostasis (GO:0042632) | 3.68338579 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 3.65605434 |
| 111 | negative regulation of wound healing (GO:0061045) | 3.65479535 |
| 112 | xenobiotic catabolic process (GO:0042178) | 3.63897998 |
| 113 | cytolysis (GO:0019835) | 3.63683709 |
| 114 | * sterol homeostasis (GO:0055092) | 3.62023031 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.61386482 |
| 116 | NAD biosynthetic process (GO:0009435) | 3.58797559 |
| 117 | flavonoid metabolic process (GO:0009812) | 3.57950628 |
| 118 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55221896 |
| 119 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55221896 |
| 120 | peptidyl-glutamic acid modification (GO:0018200) | 3.54727566 |
| 121 | opsonization (GO:0008228) | 3.53248694 |
| 122 | phenylpropanoid metabolic process (GO:0009698) | 3.46341511 |
| 123 | regulation of humoral immune response (GO:0002920) | 3.44998512 |
| 124 | * plasma lipoprotein particle organization (GO:0071827) | 3.44662362 |
| 125 | regulation of lipoprotein metabolic process (GO:0050746) | 3.35568878 |
| 126 | ethanol metabolic process (GO:0006067) | 3.32546543 |
| 127 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.25689830 |
| 128 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.25689830 |
| 129 | arginine catabolic process (GO:0006527) | 3.24484929 |
| 130 | dopamine transport (GO:0015872) | 3.19381588 |
| 131 | acute-phase response (GO:0006953) | 3.19344246 |
| 132 | * protein-lipid complex subunit organization (GO:0071825) | 3.11184672 |
| 133 | thrombin receptor signaling pathway (GO:0070493) | 3.10620824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.46664718 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.24543960 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07064291 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52866536 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28570323 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17763800 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85189099 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05484152 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97381688 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24508579 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.62038267 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.36948230 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.25399559 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.19363763 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07864666 |
| 16 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03744864 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.03354908 |
| 18 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9888134 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96192938 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.93947009 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.92781934 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86399050 |
| 23 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81460212 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.77383628 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.73141970 |
| 26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59041163 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57517658 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.55078431 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53633279 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52722639 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48308083 |
| 32 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46836479 |
| 33 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46310672 |
| 34 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.45056673 |
| 35 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44970740 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42607236 |
| 37 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42321687 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41433167 |
| 39 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41411841 |
| 40 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40500215 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37919155 |
| 42 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36942873 |
| 43 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36722421 |
| 44 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36722421 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35880332 |
| 46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34128813 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33943967 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32777550 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32329493 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30393501 |
| 51 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.28446091 |
| 52 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.26207441 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25867997 |
| 54 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.23557262 |
| 55 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22873664 |
| 56 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20395330 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19908136 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19651155 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19501427 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19337110 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19337110 |
| 62 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18143168 |
| 63 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.17099440 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11047052 |
| 65 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.10417286 |
| 66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09752205 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09508875 |
| 68 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09073206 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07676521 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07676521 |
| 71 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06774659 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06236876 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05346917 |
| 74 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04117562 |
| 75 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03288300 |
| 76 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03245363 |
| 77 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02813525 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01664712 |
| 79 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01371741 |
| 80 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99202469 |
| 81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98813338 |
| 82 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96429614 |
| 83 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96264295 |
| 84 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.96165894 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95136404 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95099459 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95032821 |
| 88 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94678257 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93754799 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93268113 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92064008 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92036895 |
| 93 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.91392246 |
| 94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91021868 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90760600 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90537518 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.90138196 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89359829 |
| 99 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89120665 |
| 100 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88824315 |
| 101 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88694644 |
| 102 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88154641 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87897005 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85975227 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85867995 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80620874 |
| 107 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78703608 |
| 108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78388299 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78364824 |
| 110 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77938466 |
| 111 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76750568 |
| 112 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76656172 |
| 113 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76636909 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73506375 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72666005 |
| 116 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72007797 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69792982 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.68064369 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.66885584 |
| 120 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66437669 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.65303425 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65069804 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65050077 |
| 124 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.62271711 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62055760 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62055760 |
| 127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61995022 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.61825340 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61588322 |
| 130 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59998149 |
| 131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58804501 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55840117 |
| 133 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55209187 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52417027 |
| 135 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52314871 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52076774 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51935945 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51713649 |
| 139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50047754 |
| 140 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49847984 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49826793 |
| 142 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47909730 |
| 143 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47870343 |
| 144 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.46844183 |
| 145 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46769432 |
| 146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46209740 |
| 147 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45520286 |
| 148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43526843 |
| 149 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42475395 |
| 150 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42388921 |
| 151 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42002657 |
| 152 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41352707 |
| 153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40993760 |
| 154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40589824 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40014140 |
| 156 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.39734290 |
| 157 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39192606 |
| 158 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.39150632 |
| 159 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.38626104 |
| 160 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37976080 |
| 161 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37593150 |
| 162 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37545355 |
| 163 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37529877 |
| 164 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37415505 |
| 165 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37347829 |
| 166 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36718235 |
| 167 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.36564285 |
| 168 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36375549 |
| 169 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35710506 |
| 170 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35584409 |
| 171 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34162782 |
| 172 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34071546 |
| 173 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33630022 |
| 174 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.33330824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.35377886 |
| 2 | MP0005360_urolithiasis | 7.57415340 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43145808 |
| 4 | MP0005365_abnormal_bile_salt | 6.16618604 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11721018 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.36530038 |
| 7 | MP0003252_abnormal_bile_duct | 3.89654918 |
| 8 | * MP0010329_abnormal_lipoprotein_level | 3.50710442 |
| 9 | MP0009840_abnormal_foam_cell | 3.32763149 |
| 10 | MP0005083_abnormal_biliary_tract | 3.06426980 |
| 11 | MP0003195_calcinosis | 2.87466040 |
| 12 | MP0005332_abnormal_amino_acid | 2.74538568 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59117976 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.28545107 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17990520 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11700827 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.06865414 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.95476016 |
| 19 | MP0003868_abnormal_feces_composition | 1.90359524 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83484029 |
| 21 | MP0001764_abnormal_homeostasis | 1.69369576 |
| 22 | MP0009697_abnormal_copulation | 1.67813497 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 1.61294809 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59833338 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 1.49223084 |
| 26 | MP0005451_abnormal_body_composition | 1.47560263 |
| 27 | MP0003011_delayed_dark_adaptation | 1.38661684 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.30592591 |
| 29 | MP0003186_abnormal_redox_activity | 1.27814906 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.23194229 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.20763874 |
| 32 | MP0003879_abnormal_hair_cell | 1.19252064 |
| 33 | MP0000598_abnormal_liver_morphology | 1.18781324 |
| 34 | MP0005410_abnormal_fertilization | 1.18642788 |
| 35 | MP0005647_abnormal_sex_gland | 1.13619668 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.13608707 |
| 37 | MP0002736_abnormal_nociception_after | 1.11033141 |
| 38 | MP0000604_amyloidosis | 1.10228299 |
| 39 | MP0008004_abnormal_stomach_pH | 1.09955135 |
| 40 | MP0009764_decreased_sensitivity_to | 1.06845442 |
| 41 | MP0004142_abnormal_muscle_tone | 1.05698450 |
| 42 | MP0003122_maternal_imprinting | 1.05070457 |
| 43 | MP0002254_reproductive_system_inflammat | 1.03724128 |
| 44 | MP0008775_abnormal_heart_ventricle | 1.03486779 |
| 45 | MP0009763_increased_sensitivity_to | 1.03077167 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.00590883 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 0.99471387 |
| 48 | MP0010368_abnormal_lymphatic_system | 0.97007124 |
| 49 | MP0004043_abnormal_pH_regulation | 0.94376393 |
| 50 | MP0001986_abnormal_taste_sensitivity | 0.93450415 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 0.91943411 |
| 52 | MP0001968_abnormal_touch/_nociception | 0.91793097 |
| 53 | MP0008469_abnormal_protein_level | 0.90534621 |
| 54 | MP0003646_muscle_fatigue | 0.89893985 |
| 55 | MP0005187_abnormal_penis_morphology | 0.89726629 |
| 56 | * MP0009642_abnormal_blood_homeostasis | 0.86497800 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 0.85646727 |
| 58 | MP0005408_hypopigmentation | 0.85531495 |
| 59 | MP0002163_abnormal_gland_morphology | 0.84996428 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.83976229 |
| 61 | MP0005376_homeostasis/metabolism_phenot | 0.80902526 |
| 62 | MP0001984_abnormal_olfaction | 0.80193327 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.78752626 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 0.78368203 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 0.77808006 |
| 66 | MP0002876_abnormal_thyroid_physiology | 0.77730138 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.76135113 |
| 68 | MP0004133_heterotaxia | 0.73790244 |
| 69 | MP0005670_abnormal_white_adipose | 0.71073022 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 0.70992893 |
| 71 | MP0008877_abnormal_DNA_methylation | 0.70987152 |
| 72 | MP0002971_abnormal_brown_adipose | 0.70118326 |
| 73 | MP0003136_yellow_coat_color | 0.67702795 |
| 74 | MP0005334_abnormal_fat_pad | 0.67449030 |
| 75 | MP0001661_extended_life_span | 0.67368593 |
| 76 | MP0003690_abnormal_glial_cell | 0.66866322 |
| 77 | MP0004130_abnormal_muscle_cell | 0.66172733 |
| 78 | MP0005266_abnormal_metabolism | 0.65873148 |
| 79 | MP0009053_abnormal_anal_canal | 0.65514103 |
| 80 | MP0005535_abnormal_body_temperature | 0.65425988 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.64788832 |
| 82 | MP0000639_abnormal_adrenal_gland | 0.62684863 |
| 83 | MP0003329_amyloid_beta_deposits | 0.62453884 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.61154657 |
| 85 | MP0009745_abnormal_behavioral_response | 0.59815962 |
| 86 | MP0001663_abnormal_digestive_system | 0.57357828 |
| 87 | MP0001756_abnormal_urination | 0.57096505 |
| 88 | MP0002089_abnormal_postnatal_growth/wei | 0.56778433 |
| 89 | MP0006035_abnormal_mitochondrial_morpho | 0.56262343 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.56206719 |
| 91 | MP0009046_muscle_twitch | 0.55821439 |
| 92 | MP0005448_abnormal_energy_balance | 0.54733189 |
| 93 | MP0002272_abnormal_nervous_system | 0.50316760 |
| 94 | MP0002822_catalepsy | 0.49035622 |
| 95 | MP0005395_other_phenotype | 0.48427273 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.46890628 |
| 97 | MP0008874_decreased_physiological_sensi | 0.46389661 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.46243474 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.45997670 |
| 100 | MP0003718_maternal_effect | 0.45926716 |
| 101 | MP0003436_decreased_susceptibility_to | 0.45914395 |
| 102 | MP0008873_increased_physiological_sensi | 0.45026885 |
| 103 | MP0001324_abnormal_eye_pigmentation | 0.44589225 |
| 104 | MP0002928_abnormal_bile_duct | 0.43854010 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.42526483 |
| 106 | MP0003075_altered_response_to | 0.41363205 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.40904095 |
| 108 | MP0003724_increased_susceptibility_to | 0.39576856 |
| 109 | MP0005166_decreased_susceptibility_to | 0.38390151 |
| 110 | MP0008872_abnormal_physiological_respon | 0.38177999 |
| 111 | * MP0003953_abnormal_hormone_level | 0.37876264 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.37593148 |
| 113 | MP0009672_abnormal_birth_weight | 0.37412588 |
| 114 | MP0004381_abnormal_hair_follicle | 0.37055138 |
| 115 | MP0006082_CNS_inflammation | 0.36738906 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.34334742 |
| 117 | MP0001853_heart_inflammation | 0.34244913 |
| 118 | MP0000249_abnormal_blood_vessel | 0.34197499 |
| 119 | MP0001243_abnormal_dermal_layer | 0.33038127 |
| 120 | MP0004883_abnormal_blood_vessel | 0.33025701 |
| 121 | MP0009115_abnormal_fat_cell | 0.32774687 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.31297703 |
| 123 | MP0002796_impaired_skin_barrier | 0.30919555 |
| 124 | MP0002168_other_aberrant_phenotype | 0.30871503 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.29764344 |
| 126 | MP0000579_abnormal_nail_morphology | 0.29190254 |
| 127 | MP0002970_abnormal_white_adipose | 0.29150822 |
| 128 | MP0002132_abnormal_respiratory_system | 0.25637078 |
| 129 | MP0001881_abnormal_mammary_gland | 0.25605330 |
| 130 | MP0005164_abnormal_response_to | 0.25217964 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.25190623 |
| 132 | MP0002090_abnormal_vision | 0.22545942 |
| 133 | MP0005058_abnormal_lysosome_morphology | 0.22394686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.55682789 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.43333683 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.36511793 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.67580257 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.65749337 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.53191964 |
| 7 | * Xanthomatosis (HP:0000991) | 5.87602985 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.62010501 |
| 9 | Complement deficiency (HP:0004431) | 5.30248230 |
| 10 | Joint hemorrhage (HP:0005261) | 4.90152446 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.86120905 |
| 12 | Hyperammonemia (HP:0001987) | 4.63904062 |
| 13 | Prolonged bleeding time (HP:0003010) | 4.51608768 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.50443371 |
| 15 | Epidermoid cyst (HP:0200040) | 4.48944129 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.44165022 |
| 17 | Hyperglycinemia (HP:0002154) | 4.43805040 |
| 18 | Purpura (HP:0000979) | 4.36324918 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.28134721 |
| 20 | Ketosis (HP:0001946) | 4.24557166 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23774147 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.21932429 |
| 23 | Fat malabsorption (HP:0002630) | 4.15508372 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.10279237 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10083328 |
| 26 | Increased mean platelet volume (HP:0011877) | 3.92577672 |
| 27 | Hyperglycinuria (HP:0003108) | 3.92127349 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.91929535 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.91929535 |
| 30 | Abnormality of complement system (HP:0005339) | 3.86827200 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.86782517 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.85640932 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81944130 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71025724 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.65832685 |
| 36 | Epistaxis (HP:0000421) | 3.57759132 |
| 37 | Abnormal platelet volume (HP:0011876) | 3.54748753 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.38043768 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36749543 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33935045 |
| 41 | Steatorrhea (HP:0002570) | 3.12937829 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.11755143 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 3.07432233 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 3.05381993 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04233695 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 3.01820005 |
| 47 | Spontaneous abortion (HP:0005268) | 3.01619198 |
| 48 | Ketoacidosis (HP:0001993) | 3.00917357 |
| 49 | Myocardial infarction (HP:0001658) | 2.97563045 |
| 50 | Petechiae (HP:0000967) | 2.83688699 |
| 51 | Metabolic acidosis (HP:0001942) | 2.77583223 |
| 52 | Skin nodule (HP:0200036) | 2.76698049 |
| 53 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.71218878 |
| 54 | Abnormality of alanine metabolism (HP:0010916) | 2.71218878 |
| 55 | Hyperalaninemia (HP:0003348) | 2.71218878 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.68361170 |
| 57 | Vascular calcification (HP:0004934) | 2.63966569 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.63530076 |
| 59 | Acanthocytosis (HP:0001927) | 2.62155510 |
| 60 | Lethargy (HP:0001254) | 2.60492008 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.59126874 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59126874 |
| 63 | Fair hair (HP:0002286) | 2.53289614 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.50460983 |
| 65 | Glycosuria (HP:0003076) | 2.50460983 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.49734102 |
| 67 | Glomerulonephritis (HP:0000099) | 2.49227876 |
| 68 | Impaired platelet aggregation (HP:0003540) | 2.48346454 |
| 69 | Abnormal platelet function (HP:0011869) | 2.48346454 |
| 70 | Joint swelling (HP:0001386) | 2.47766930 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.46644690 |
| 72 | Mitral stenosis (HP:0001718) | 2.46431517 |
| 73 | Spastic diplegia (HP:0001264) | 2.45930950 |
| 74 | Arthropathy (HP:0003040) | 2.44783528 |
| 75 | Cholelithiasis (HP:0001081) | 2.43691886 |
| 76 | Cerebral edema (HP:0002181) | 2.41895328 |
| 77 | Gout (HP:0001997) | 2.38151306 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36118660 |
| 79 | Irritability (HP:0000737) | 2.34457407 |
| 80 | Neonatal onset (HP:0003623) | 2.34007421 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.33894679 |
| 82 | Cholecystitis (HP:0001082) | 2.32880956 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.32880956 |
| 84 | Malnutrition (HP:0004395) | 2.30319782 |
| 85 | Amyloidosis (HP:0011034) | 2.29334925 |
| 86 | Decreased central vision (HP:0007663) | 2.29092353 |
| 87 | Gingival bleeding (HP:0000225) | 2.25791084 |
| 88 | Esophageal varix (HP:0002040) | 2.19705620 |
| 89 | Menorrhagia (HP:0000132) | 2.19397781 |
| 90 | Pancreatitis (HP:0001733) | 2.14959992 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 2.13685698 |
| 92 | Thrombophlebitis (HP:0004418) | 2.10670573 |
| 93 | Late onset (HP:0003584) | 2.10607676 |
| 94 | Brushfield spots (HP:0001088) | 2.09936796 |
| 95 | Enlarged kidneys (HP:0000105) | 2.08530183 |
| 96 | Poikilocytosis (HP:0004447) | 2.08466125 |
| 97 | Optic neuritis (HP:0100653) | 2.07917865 |
| 98 | Retrobulbar optic neuritis (HP:0100654) | 2.07917865 |
| 99 | Pulmonary embolism (HP:0002204) | 2.07336282 |
| 100 | Vomiting (HP:0002013) | 2.06523899 |
| 101 | Opisthotonus (HP:0002179) | 2.04311485 |
| 102 | Abnormality of the renal cortex (HP:0011035) | 2.03744575 |
| 103 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.03364994 |
| 104 | Abnormal biliary tract physiology (HP:0012439) | 2.02836941 |
| 105 | Bile duct proliferation (HP:0001408) | 2.02836941 |
| 106 | Generalized aminoaciduria (HP:0002909) | 2.02661868 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 2.01314629 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.00950550 |
| 109 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99671380 |
| 110 | Hypothermia (HP:0002045) | 1.97257475 |
| 111 | Rickets (HP:0002748) | 1.95069712 |
| 112 | Osteomalacia (HP:0002749) | 1.92845801 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 1.91441095 |
| 114 | Abnormal pupillary function (HP:0007686) | 1.89989323 |
| 115 | Abnormal cartilage morphology (HP:0002763) | 1.89642012 |
| 116 | Hypophosphatemic rickets (HP:0004912) | 1.89056889 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88688381 |
| 118 | Facial shape deformation (HP:0011334) | 1.87799980 |
| 119 | Potter facies (HP:0002009) | 1.87799980 |
| 120 | Chronic hepatic failure (HP:0100626) | 1.84387446 |
| 121 | Elevated hepatic transaminases (HP:0002910) | 1.83637919 |
| 122 | Thyroid-stimulating hormone excess (HP:0002925) | 1.83634762 |
| 123 | Renal cortical cysts (HP:0000803) | 1.82842329 |
| 124 | Hydroxyprolinuria (HP:0003080) | 1.82825463 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 1.82825463 |
| 126 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82245009 |
| 127 | Abolished electroretinogram (ERG) (HP:0000550) | 1.81092568 |
| 128 | Abnormal urine output (HP:0012590) | 1.79872748 |
| 129 | Status epilepticus (HP:0002133) | 1.78552683 |
| 130 | Alkalosis (HP:0001948) | 1.77877770 |
| 131 | Nephritis (HP:0000123) | 1.75899903 |
| 132 | Pancreatic cysts (HP:0001737) | 1.74387588 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.73538979 |
| 134 | Reticulocytosis (HP:0001923) | 1.72891706 |
| 135 | Congenital stationary night blindness (HP:0007642) | 1.72229243 |
| 136 | Keratoconjunctivitis (HP:0001096) | 1.71020968 |
| 137 | Hyperphosphaturia (HP:0003109) | 1.70861067 |
| 138 | Generalized hypopigmentation of hair (HP:0011358) | 1.70457449 |
| 139 | Gangrene (HP:0100758) | 1.66627412 |
| 140 | Orchitis (HP:0100796) | 1.66467802 |
| 141 | Hyperventilation (HP:0002883) | 1.65464282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.30876839 |
| 2 | SIK1 | 4.63866873 |
| 3 | FGFR4 | 4.58073096 |
| 4 | ERN1 | 4.39619699 |
| 5 | TLK1 | 3.14648488 |
| 6 | TAOK3 | 3.07930232 |
| 7 | ADRBK2 | 2.93771107 |
| 8 | INSRR | 2.82091819 |
| 9 | WNK4 | 2.70655783 |
| 10 | MST4 | 2.70567234 |
| 11 | ERBB4 | 2.65738907 |
| 12 | ZAK | 2.41861346 |
| 13 | PKN2 | 2.34322906 |
| 14 | MAP2K4 | 2.24212474 |
| 15 | MAP4K2 | 2.20675938 |
| 16 | WNK3 | 2.10975724 |
| 17 | ACVR1B | 2.10872636 |
| 18 | MST1R | 2.05985769 |
| 19 | FLT3 | 1.96835229 |
| 20 | PIK3CG | 1.92862099 |
| 21 | TRIB3 | 1.84737955 |
| 22 | MAPK11 | 1.84189026 |
| 23 | CAMKK2 | 1.83876208 |
| 24 | TYK2 | 1.82320801 |
| 25 | STK39 | 1.73673856 |
| 26 | DAPK2 | 1.71916704 |
| 27 | MAPKAPK3 | 1.71883481 |
| 28 | BRSK2 | 1.68947978 |
| 29 | BMPR1B | 1.67700709 |
| 30 | LMTK2 | 1.63923463 |
| 31 | NUAK1 | 1.52776003 |
| 32 | LATS1 | 1.48937159 |
| 33 | ABL2 | 1.46301075 |
| 34 | PTK6 | 1.44469837 |
| 35 | TXK | 1.41687869 |
| 36 | TNIK | 1.38226256 |
| 37 | KDR | 1.36867662 |
| 38 | NEK9 | 1.36423524 |
| 39 | FRK | 1.35396168 |
| 40 | FGFR2 | 1.35289167 |
| 41 | NTRK3 | 1.31736415 |
| 42 | EIF2AK1 | 1.25012757 |
| 43 | PTK2B | 1.21830794 |
| 44 | GRK6 | 1.21071229 |
| 45 | JAK2 | 1.20389524 |
| 46 | TEC | 1.18902129 |
| 47 | MYLK | 1.18797589 |
| 48 | MAP2K3 | 1.18334439 |
| 49 | TBK1 | 1.16572747 |
| 50 | BMX | 1.14590120 |
| 51 | MAP3K7 | 1.14430395 |
| 52 | NLK | 1.13701239 |
| 53 | MAP3K10 | 1.12364753 |
| 54 | MAP3K14 | 1.09615265 |
| 55 | PRKAA2 | 1.05723723 |
| 56 | PAK3 | 1.05199293 |
| 57 | CASK | 1.04633914 |
| 58 | STK16 | 1.04569648 |
| 59 | JAK1 | 1.03822238 |
| 60 | PINK1 | 1.02944792 |
| 61 | MAPK13 | 1.01856430 |
| 62 | SIK2 | 1.01343842 |
| 63 | MAPK4 | 0.97116660 |
| 64 | STK3 | 0.95302047 |
| 65 | PLK2 | 0.95081385 |
| 66 | PRKCZ | 0.92934047 |
| 67 | PIK3CA | 0.92805726 |
| 68 | ADRBK1 | 0.92284324 |
| 69 | ERBB2 | 0.91501149 |
| 70 | FER | 0.91256683 |
| 71 | MAP3K3 | 0.90377168 |
| 72 | SYK | 0.86288207 |
| 73 | MAP3K11 | 0.85609728 |
| 74 | BTK | 0.84057431 |
| 75 | STK24 | 0.83947286 |
| 76 | FGR | 0.83587672 |
| 77 | IKBKB | 0.83321991 |
| 78 | TRIM28 | 0.82496178 |
| 79 | MAPK12 | 0.81181994 |
| 80 | CDK6 | 0.80752765 |
| 81 | MET | 0.80198773 |
| 82 | MAPK15 | 0.79667835 |
| 83 | PRKCE | 0.79566063 |
| 84 | MAP3K4 | 0.79555805 |
| 85 | CSF1R | 0.78652207 |
| 86 | TIE1 | 0.76303621 |
| 87 | EPHB1 | 0.76256644 |
| 88 | CSK | 0.75908771 |
| 89 | GRK5 | 0.75162912 |
| 90 | PRKACG | 0.73932730 |
| 91 | STK38L | 0.72556533 |
| 92 | OXSR1 | 0.72198940 |
| 93 | TNK2 | 0.71080683 |
| 94 | DYRK2 | 0.70898325 |
| 95 | DYRK1B | 0.69528283 |
| 96 | EPHA3 | 0.67776300 |
| 97 | IRAK3 | 0.65741945 |
| 98 | MAP2K6 | 0.64975680 |
| 99 | CAMK2G | 0.64405213 |
| 100 | CAMK1D | 0.63487601 |
| 101 | GSK3A | 0.63255643 |
| 102 | TGFBR2 | 0.62486446 |
| 103 | PRKAA1 | 0.62302175 |
| 104 | PRKG1 | 0.61742442 |
| 105 | RIPK1 | 0.61685132 |
| 106 | IKBKE | 0.61171510 |
| 107 | PRKCQ | 0.60965721 |
| 108 | MAPK7 | 0.59595191 |
| 109 | SGK3 | 0.57303825 |
| 110 | TAOK2 | 0.56305838 |
| 111 | FGFR3 | 0.55970709 |
| 112 | PRKACA | 0.55830991 |
| 113 | MAP3K13 | 0.54367571 |
| 114 | CSNK1G1 | 0.53733998 |
| 115 | GRK1 | 0.53658167 |
| 116 | MAP4K1 | 0.51278350 |
| 117 | PTK2 | 0.50646719 |
| 118 | MAP3K12 | 0.49991609 |
| 119 | PDPK1 | 0.48939695 |
| 120 | BCR | 0.46723036 |
| 121 | PHKG2 | 0.44553952 |
| 122 | PHKG1 | 0.44553952 |
| 123 | CSNK1D | 0.44135518 |
| 124 | CDK4 | 0.43952044 |
| 125 | IGF1R | 0.43554237 |
| 126 | ILK | 0.43435967 |
| 127 | MAP3K5 | 0.43412191 |
| 128 | PRKCG | 0.41827666 |
| 129 | EPHA4 | 0.41760697 |
| 130 | MAP2K1 | 0.40680224 |
| 131 | PRKCB | 0.39823483 |
| 132 | SGK2 | 0.39733271 |
| 133 | RET | 0.39028108 |
| 134 | CAMKK1 | 0.37865197 |
| 135 | PBK | 0.37364345 |
| 136 | PDK2 | 0.36167849 |
| 137 | PDK1 | 0.34786640 |
| 138 | RIPK4 | 0.34600743 |
| 139 | ICK | 0.33885123 |
| 140 | EGFR | 0.33293774 |
| 141 | MTOR | 0.31648465 |
| 142 | PKN1 | 0.31509730 |
| 143 | CSNK1G2 | 0.31493617 |
| 144 | CAMK1 | 0.31087326 |
| 145 | CSNK1G3 | 0.31073893 |
| 146 | MAP3K6 | 0.30876437 |
| 147 | CAMK4 | 0.30051488 |
| 148 | MAP3K2 | 0.28398832 |
| 149 | CAMK2A | 0.28336405 |
| 150 | CSNK1A1 | 0.28170910 |
| 151 | SGK223 | 0.25320010 |
| 152 | SGK494 | 0.25320010 |
| 153 | MAP3K1 | 0.24951720 |
| 154 | PRKCA | 0.24798008 |
| 155 | ABL1 | 0.21747245 |
| 156 | CSNK1A1L | 0.21169493 |
| 157 | KIT | 0.21078736 |
| 158 | IRAK2 | 0.20782291 |
| 159 | ITK | 0.19646112 |
| 160 | BLK | 0.18795634 |
| 161 | LYN | 0.18629409 |
| 162 | IRAK1 | 0.18189381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53386430 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62149950 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39265206 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37979228 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06469357 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78720550 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70651099 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68501360 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65666224 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54812207 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48631686 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39146718 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26216161 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15982156 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15615912 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06556034 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97304111 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95211752 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94869884 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93175195 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90925793 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85146313 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79787702 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79548450 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78300454 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74017941 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71909966 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71815562 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71370933 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67419816 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63652117 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58933765 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56500371 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50485838 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49366616 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48494686 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44748942 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36129759 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35075189 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34230702 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30332889 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27366016 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22357384 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.19445165 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19356900 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19344879 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16998138 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12333212 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01252287 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00549243 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98962206 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97978086 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96635247 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95700917 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95258071 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86119855 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84502254 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81352366 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80545651 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78611859 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69039570 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63784526 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.62069383 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58329601 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58236548 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.57431698 |
| 67 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52626898 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51591995 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50659316 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45641514 |
| 71 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45217772 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42636201 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38679573 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.34006540 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30124406 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29305472 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27317721 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26106208 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24912780 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.24431987 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23788783 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22885503 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.22242522 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22118381 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20300082 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19714514 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.15920406 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.15364712 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14037413 |
| 90 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.13208428 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.11588283 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.10452998 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07871972 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.07700202 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.03808528 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.02867703 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.02798004 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00416989 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2521367 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2519921 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | -0.2477252 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2461590 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2390999 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1974386 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1945370 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1925003 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | -0.1827209 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1725229 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1720013 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1673639 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1616574 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1502248 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1384399 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1306552 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1129755 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1088448 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0846444 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0698325 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0425226 |

